From major journals, first or last author from the Institute for Cancer Research
Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab
Biomed Pharmacother, 191, 118550 (in press)
DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
Nat Immunol (in press)
DOI 10.1038/s41590-025-02252-1, PubMed 40866620
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937